However, small hairpin RNA (shRNA) deletion of NF-1 was not sufficient in the insensitive NB cell lines to confer sensitivity to SHP2 inhibition, suggesting pathway manipulation in NBs that are already developed is not sufficient to create a vulnerability to SHP2 inhibition (Figures S10A and S10B). This evidence concerns the gene PTPN11 and neuroblastoma.